Oncolytics Biotech (ONCY) Return on Capital Employed Growth (5y) (2015 - 2025)
Oncolytics Biotech (ONCY) Return on Capital Employed Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn |
| 10 | Oncolytics Biotech | 76.67 Mn | 76.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -33,067.00 |
| Jun 30, 2025 | -18,150.00 |
| Sep 30, 2024 | 2,681.00 |
| Jun 30, 2024 | -1,138.00 |
| Dec 31, 2023 | -15,420.00 |
| Sep 30, 2023 | -25,737.00 |
| Jun 30, 2023 | -26,726.00 |
| Mar 31, 2023 | -15,585.00 |
| Dec 31, 2022 | -7,490.00 |
| Sep 30, 2022 | -14,397.00 |
| Jun 30, 2022 | -10,597.00 |
| Mar 31, 2022 | -9,214.00 |
| Dec 31, 2021 | -5,350.00 |
| Sep 30, 2021 | 7,693.00 |
| Jun 30, 2021 | 5,477.00 |
| Mar 31, 2021 | 3,717.00 |
| Dec 31, 2020 | -1,009.00 |
| Sep 30, 2020 | -6,385.00 |
| Jun 30, 2020 | -6,106.00 |
| Sep 30, 2019 | -7,740.00 |